𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Botulinum toxin in the treatment of lingual movement disorders

✍ Scribed by Neema Kasravi; Mandar S. Jog

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
66 KB
Volume
24
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Lingual movement disorders are a rare but serious manifestation of neurologic disease, which have the potential to cause significant morbidity. Traditionally, these disorders were treated with pharmacotherapy achieving only limited results. Several case series have demonstrated the effectiveness of Botulinum toxin injection for the management of focal lingual movement disorders; however, apprehension persists regarding intralingual injections due to the risk of dysphagia. Here, we report seven patients with lingual movement disorders treated with intralingual Botoxβ„’ (Allergan product) injections via a novel superior approach into the genioglossus over a period of 3 to 72 months. All patients experienced a marked improvement in their abnormal tongue movements with no substantial bleeding or dysphagia. Lingual Botulinum toxin injection should be considered a safe and viable treatment option for a variety of disorders affecting the tongue. Β© 2009 Movement Disorder Society

πŸ“œ SIMILAR VOLUMES

Botulinum toxin treatment of secretory d
Botulinum toxin treatment of secretory disorders
✍ Markus Naumann; Wolfgang Jost πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 59 KB

Botulinum neurotoxin serotype A (BoNT/A) has revolutionised the treatment of a variety of autonomic hypersecretory disorders. Several open and controlled studies indicate that BoNT/A is a safe and effective treatment for focal hyperhidrosis of the axillae and palms, for gustatory sweating, and for s

Botulinum toxin in the treatment of dyst
Botulinum toxin in the treatment of dystonic tics
✍ Dr. Joseph Jankovic πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 236 KB

## Abstract Botulinum toxin (BTX) injections provide effective treatment for a variety of disorders manifested by inappropriate muscle contractions, but its efficacy in the treatment of tics has not been previously studied. Ten male patients 13–53 years of age who were diagnosed with Tourette's syn

Perioperative use of botulinum toxin for
Perioperative use of botulinum toxin for movement disorder–induced cervical spine disease
✍ Dr. Charles H. Adler; Richard S. Zimmerman; Mark K. Lyons; Fred Simeone; Mitchel πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 284 KB

Patients with cervical dystonia or tics of the nuchal muscles can develop serious cervical spine disease. We report a series of four patients who received botulinum toxin injections to control their movement disorders prior to their required surgery. One patient with cervical tic-induced radiculomye

Botulinum toxin treatment of lateral axi
Botulinum toxin treatment of lateral axial dystonia in parkinsonism
✍ Laura Bonanni; Astrid Thomas; Sara Varanese; Vincenzo Scorrano; Marco Onofrj πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 130 KB

## Abstract Lateral axial dystonia (LAD) has been described in patients with Parkinson's disease (PD), but treatment might be more controversial than treatment of LAD in other neurological conditions. Our study was designed as a blinded cross‐over with botulinum toxin (BTX) and placebo in order to